PKPD Modeling and Simulations to Support Biosimilar Development of Biphasic Insulin Aspart 30

药效学 医学 药代动力学 人口 门冬氨酸胰岛素 药理学 统计 生物仿制药 胰岛素 数学 内科学 低血糖 环境卫生
作者
Aleksandr V. Petrov,Bella R. Zinnatulina,Драй Роман Васильевич,Т. Л. Каронова,Ekaterina Koksharova,Artem R. Dorotenko,И. Е. Макаренко
出处
期刊:Clinical pharmacology in drug development [Wiley]
卷期号:11 (12): 1457-1466 被引量:2
标识
DOI:10.1002/cpdd.1152
摘要

Abstract This paper presents an analysis of data from a comparative study of biosimilarity in terms of pharmacokinetics and pharmacodynamics in healthy volunteers using a hyperinsulinemic euglycemic clamp for reference and test biphasic insulin aspart 30 (BIAsp 30). As a result of the study, one of the secondary pharmacodynamic (PD) endpoints did not satisfy the classical criterion of 80%–125% (the lower limit for PD parameter area under the glucose infusion rate–time curve [] turned out to be 79.5%). The main hypothesis explaining this result is that the sample size is insufficient to conduct a PD test with 90% statistical power, since the sample size has been calculated based on the coefficient of variation (CV) of pharmacokinetic (PK) parameters. To test this hypothesis, population PKPD (popPKPD) modeling and subsequent simulations of the required number of PD profiles were used. Two popPKPD models were constructed (a one‐compartment double simultaneous absorption model for PK and an effect compartment Emax model for PD) to describe the PKPD data of reference and test insulins. As a result, using real data along with model‐based simulation data, a biosimilarity test for PD was performed, and the lower limit for became 82.6%, while the CV decreased from 31.7% to 24.1%. Thus, popPKPD modeling and simulations have been shown to be effective in interpreting and supporting the results of clinical biosimilarity trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
充电宝的应助被西贝采纳,获得10
1秒前
SciGPT的应助被铁锤牛马版采纳,获得30
1秒前
fbomu完成签到,获得积分10
2秒前
2秒前
丘比特的应助被魂梦与君同采纳,获得10
2秒前
Luciana完成签到,获得积分10
3秒前
4秒前
稀里糊涂完成签到,获得积分10
4秒前
4秒前
辛勤念之发布了新的文献求助10
4秒前
星辰大海的应助被科研通管家采纳,获得10
4秒前
4秒前
丘比特的应助被科研通管家采纳,获得10
4秒前
李爱国的应助被科研通管家采纳,获得10
4秒前
香蕉觅云的应助被科研通管家采纳,获得10
5秒前
5秒前
5秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
5秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
5秒前
5秒前
情怀的应助被科研通管家采纳,获得20
5秒前
丘比特的应助被科研通管家采纳,获得10
6秒前
充电宝的应助被科研通管家采纳,获得20
6秒前
6秒前
Cr的应助被科研通管家采纳,获得10
6秒前
wanquan完成签到,获得积分10
6秒前
丘比特的应助被科研通管家采纳,获得10
6秒前
6秒前
7秒前
结实楷瑞完成签到 ,获得积分10
7秒前
Leon完成签到,获得积分10
7秒前
7秒前
7秒前
迟书问剑完成签到 ,获得积分10
8秒前
LONG发布了新的文献求助10
9秒前
Leon发布了新的文献求助10
10秒前
小二郎的应助被Emma_C2H4采纳,获得10
10秒前
10秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183449
求助须知:如何正确求助?哪些是违规求助? 9572834
关于积分的说明 21827509
捐赠科研通 7780646
什么是DOI,文献DOI怎么找? 3434016
关于科研通互助平台的介绍 2558189
邀请新用户注册赠送积分活动 2480371